Name | Zedoarondiol |
---|---|
Synonyms | ZEDOARONDIOL |
Description | Zedoarondiol, a sesquiterpene lactone compound, with antioxidant and anti-inflammatory activity. Zedoarondiol can be used for atherosclerosis research[1][2]. |
---|---|
Related Catalog | |
In Vitro | Zedoarondiol (5-20 μg/mL) attenuates HUVECs injury, up-regulated SOD activity, suppressed formation of MDA and ROS, and secretion and protein expression of IL-1β, TNF-α, and MCP-1 in injured HUVECs induced by oxidized low-density lipoprotein (ox-LDL)[1]. Zedoarondiol induces nuclear Nrf2 translocation from cytoplasm into nucleus and up-regulated expression of HO-1, NQO1, and Nrf2 in nucleus[1]. Zedoarondiol suppresses PDGF-BB-induced vascular smooth muscle cells (VSMCs) proliferation and DNA synthesis, and induces cell cycle arrest in G0/G1 phase. In addition, Zedoarondiol activates AMPK and ACC, inhibited the phosphorylation of mTOR and p70S6K, increases the expression of p53 and p21, and decreases the expression of CDK2 and cyclin E[1]. |
References |
Density | 1.1±0.1 g/cm3 |
---|---|
Boiling Point | 396.8±42.0 °C at 760 mmHg |
Molecular Formula | C15H24O3 |
Molecular Weight | 252.35 |
Flash Point | 207.9±24.4 °C |
Exact Mass | 252.172546 |
LogP | 1.63 |
Vapour Pressure | 0.0±2.1 mmHg at 25°C |
Index of Refraction | 1.529 |